The corresponding signaling pathways included VEGF, TNF, HIF, NAFLD, CYP450, hepatitis, etc. The inhibitory effects of PTUPB on sEH, COX-2, and TGF-β were also observed in our study. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.